Diabetes, Diabetes Type 2, Pre-diabetes
Conditions
Keywords
Viome, Diabetes Type 2, Diabetes, Pre-diabetes, VPNP, Nutrition, Supplements, Precision
Brief summary
Participants who were previously Viome costumers who signed informed consent to participate and self reported type 2 diabetes or pre-diabetes were enrolled. They provided stool samples to VIOME and were provided with precision diet and supplement recommendations. The information obtained from this study is used to train a model to predict diabetes and/or risks of developing diabetes.
Interventions
Precision diet and supplement recommendations based on participants' microbiome results.
Sponsors
Study design
Intervention model description
Participants all received diet and supplement recommendations based on their microbiome results.
Eligibility
Inclusion criteria
* Viome customer * GI test collected at home using Viome test kit * US citizen * 18+ years old * Is not participating in any other Viome study * Must have answered the following on-boarding question with the indicated answer: Do you or did you ever have diabetes or prediabetes? * Signed and dated informed consent prior to any trial-specific procedures are performed * Able to speak and read English * Willing and able to follow the trial instructions
Exclusion criteria
* Unable/unwilling to complete the informed consent form and the questionnaires
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Difference in VIOME's Type 2 diabetes risk score | ~3 months | Type 2 diabetes risk score is computed using Viome's molecular data from stool and HBA1C level self reported. The risk score is 1-100. 1 Indicates a low chance of developing T2D and 100 indicates a high chance of developing T2D. |
Countries
United States